REN and diabetic retinopathy: The beneficial effects of anti-hypertensive medications that target the renin-angiotensin-aldosterone system (RAAS) in DR and DME have been evaluated in several clinical trials, such as the Diabetic Retinopathy Candesartan Trials (DIRECT) and Renin-Angiotensin System Study (RASS).